Phase I trials are a critical first step in the study of novel therapeutic approaches. They follow years of development in the laboratory, and precede Phase II and III trials where testing of the drug becomes more focused yet is conducted on a wider scale.
The primary goals of Phase I trials are to identify the recommended dose, schedule and pharmacologic behaviour of new agents or new combinations of agents, and to describe the adverse effects of treatment. In cancer therapeutics, such studies have particular challenges. In general, because of the nature of the effects of treatment, most studies are conducted in patients with advanced malignancy, rather than in healthy volunteers. Furthermore, the endpoints of these trials are usually measures of adverse effects, but increasingly investigators are interested in assessment of the effects of new drugs on their molecular target. These factors render the design, conduct, analysis and ethical aspects of Phase I cancer clinical trials unique.
This book provides a practical guide to Phase I cancer trials and is appropriate for oncology trainees or specialists interested in understanding cancer drug development. Topics covered include preclinical requirements needed for first-in-man investigation of new agents, principles and statistical design, ethical considerations of Phase I studies, pharmacokinetics, pharmacodynamics, and studies in special populations. Practical information on protocol development, study activation and conduct, as well as how to write reports of the results, are incorporated. Numerous appendices offer document templates to use in Phase I study development, and examples from actual Phase I trials are interspersed throughout, making this a true 'hands-on' guide.
In an exciting time in cancer research, as the number and type of new potential anti-cancer drugs is increasing dramatically, this book provides much needed information on the first stage in getting a drug approved.
"Sinopsis" puede pertenecer a otra edición de este libro.
Elizabeth Eisenhauer was appointed to the Board of Directors of the National Cancer Institute of Canada in 2002, and will become President in June 2006. Through her work with the IND program and NCIC CTG, she has co-ordinated over 170 Phase I, II and III trials carried out across Canada, the US and Europe.
Marc Buyse founded the International Drug Development Institute (IDDI) in 1991. In addition to his current posts, he has previously been President of the International Society for Clinical Biostatistics and a Board Member of the Society for Clinical Trials. He has an editorial role in the following journals: Biometrical Journal, Clinical Trials, Journal of Clinical Oncology, and Statistical Methods in Medical Research.
"Sobre este título" puede pertenecer a otra edición de este libro.
Librería: Studibuch, Stuttgart, Alemania
paperback. Condición: Gut. 360 Seiten; 9780198567196.3 Gewicht in Gramm: 1. Nº de ref. del artículo: 1009318
Cantidad disponible: 1 disponibles
Librería: bookmarathon, Emmendingen, BW, Alemania
Condición: Sehr gut. Auflage: New. 360 Seiten Leichte Lagerspuren! Signatur auf dem Innencover, von wem auch immer. Sie erhalten eine Rechnung mit der darin ausgewiesenen MwSt. Sprache: Englisch Gewicht in Gramm: 554 23,1 x 1,5 x 15,5 cm, Taschenbuch. Nº de ref. del artículo: 11696
Cantidad disponible: 1 disponibles
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
Condición: new. Questo è un articolo print on demand. Nº de ref. del artículo: af3b237878bcb0dac1aec769ce93c186
Cantidad disponible: Más de 20 disponibles
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Condición: New. Nº de ref. del artículo: 4253092-n
Cantidad disponible: Más de 20 disponibles
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
Condición: New. Nº de ref. del artículo: 4253092-n
Cantidad disponible: Más de 20 disponibles
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Condición: As New. Unread book in perfect condition. Nº de ref. del artículo: 4253092
Cantidad disponible: Más de 20 disponibles
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Condición: New. Phase I trials are the first step in the study of novel therapeutic approaches. They aim to identify the recommended dose, schedule and pharamcologic behaviour of new drugs, and to describe the adverse effects of treatment. This practical guide discusses the design, conduct, analysis and ethical aspects of Phase I cancer trials. Num Pages: 360 pages, 20 black and white line illustrations, numerous tables. BIC Classification: MJCL; MJF; MMG. Category: (P) Professional & Vocational. Dimension: 232 x 158 x 19. Weight in Grams: 506. . 2006. Paperback. . . . . Nº de ref. del artículo: V9780198567196
Cantidad disponible: Más de 20 disponibles
Librería: AussieBookSeller, Truganina, VIC, Australia
Paperback. Condición: new. Paperback. Phase I trials are a critical first step in the study of novel therapeutic approaches. They follow years of development in the laboratory, and precede Phase II and III trials where testing of the drug becomes more focused yet is conducted on a wider scale.The primary goals of Phase I trials are to identify the recommended dose, schedule and pharmacologic behaviour of new agents or new combinations of agents, and to describe the adverseeffects of treatment. In cancer therapeutics, such studies have particular challenges. In general, because of the nature of the effects of treatment, most studies are conducted in patients with advancedmalignancy, rather than in healthy volunteers. Furthermore, the endpoints of these trials are usually measures of adverse effects, but increasingly investigators are interested in assessment of the effects of new drugs on their molecular target. These factors render the design, conduct, analysis and ethical aspects of Phase I cancer clinical trials unique.This book provides a practical guide to Phase I cancer trials and is appropriate for oncology trainees or specialistsinterested in understanding cancer drug development. Topics covered include preclinical requirements needed for first-in-man investigation of new agents, principles and statistical design, ethicalconsiderations of Phase I studies, pharmacokinetics, pharmacodynamics, and studies in special populations. Practical information on protocol development, study activation and conduct, as well as how to write reports of the results, are incorporated. Numerous appendices offer document templates to use in Phase I study development, and examples from actual Phase I trials are interspersed throughout, making this a true 'hands-on' guide.In an exciting time in cancer research,as the number and type of new potential anti-cancer drugs is increasing dramatically, this book provides much needed information on the first stage in getting a drug approved. Phase I trials are the first step in the study of novel therapeutic approaches. They aim to identify the recommended dose, schedule and pharamcologic behaviour of new drugs, and to describe the adverse effects of treatment. This practical guide discusses the design, conduct, analysis and ethical aspects of Phase I cancer trials. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. Nº de ref. del artículo: 9780198567196
Cantidad disponible: 1 disponibles
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Condición: New. In English. Nº de ref. del artículo: ria9780198567196_new
Cantidad disponible: Más de 20 disponibles
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
Condición: As New. Unread book in perfect condition. Nº de ref. del artículo: 4253092
Cantidad disponible: Más de 20 disponibles